We aimed to test the hypothesis that the inducible form of nitric oxide synthase (iNOS) contributes to the development of an early subnormal retinal oxygenation response in preclinical models of diabetic retinopathy. In urethane anesthetized Sprague Dawley rats or C57BL/6 mice, functional magnetic resonance imaging was used to noninvasively measure the change in retinal oxygen tension (⌬PO 2 ) during a carbogen-inhalation challenge. In the rat experiments, the retinal ⌬PO 2 of the following groups were compared: control rats (n ‫؍‬ 9), 3-month diabetic rats (n ‫؍‬ 5), and 3-month diabetic rats treated orally with L-N(6)-(1-iminoethyl)lysine 5-tetrazole amide, a prodrug of an inhibitor of iNOS (n ‫؍‬ 6). In addition, the retinal ⌬PO 2 of the following mouse groups were compared: C57BL/6 mice (n ‫؍‬ 20), C57BL/6-Nos2 tm1Lau mice (n ‫؍‬ 10), 4-month diabetic mice (n ‫؍‬ 13), and 4-month diabetic knockout mice (n ‫؍‬ 6). Only the ⌬PO 2 of the superior hemiretina of the diabetic rat and mice groups were significantly subnormal (P < 0.05). The superior ⌬PO 2 of the diabetic rats treated with the prodrug was not significantly (P > 0.05) different from their respective normal controls. In the mice experiments, the superior retinal ⌬PO 2 of the iNOS null mice was not statistically different (P > 0.05) from that of normal control mice. iNOS is required for the development of an early subnormal ⌬PO 2 in experimental diabetic retinopathy. Diabetes 53: [173][174][175][176][177][178] 2004 N itric oxide (NO), a potent regulator of retinal vascular function, is elevated in the vitreous humor of patients with proliferative diabetic retinopathy and with tractional retinal detachment, as well as in the retina of rodents, 2-4 months after the induction of diabetes (1-4). NO synthase (NOS) converts L-arginine to NO and L-citrulline. Excessive NO production by the inducible isoform of NOS (iNOS) in particular has been implicated in the pathogenesis of various ocular diseases (5,6). iNOS is induced in the retina in diabetes, but it is not yet known if iNOS regulates aspects of retinal circulatory pathophysiology associated with diabetes (4).
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We aimed to test the hypothesis that the inducible form of nitric oxide synthase (iNOS) contributes to the development of an early subnormal retinal oxygenation response in preclinical models of diabetic retinopathy. In urethane anesthetized Sprague Dawley rats or C57BL/6 mice, functional magnetic resonance imaging was used to noninvasively measure the change in retinal oxygen tension (⌬PO 2 ) during a carbogen-inhalation challenge. In the rat experiments, the retinal ⌬PO 2 of the following groups were compared: control rats (n ‫؍‬ 9), 3-month diabetic rats (n ‫؍‬ 5), and 3-month diabetic rats treated orally with L-N(6)-(1-iminoethyl)lysine 5-tetrazole amide, a prodrug of an inhibitor of iNOS (n ‫؍‬ 6). In addition, the retinal ⌬PO 2 of the following mouse groups were compared: C57BL/6 mice (n ‫؍‬ 20), C57BL/6-Nos2 tm1Lau mice (n ‫؍‬ 10), 4-month diabetic mice (n ‫؍‬ 13), and 4-month diabetic knockout mice (n ‫؍‬ 6). Only the ⌬PO 2 of the superior hemiretina of the diabetic rat and mice groups were significantly subnormal (P < 0.05). The superior ⌬PO 2 of the diabetic rats treated with the prodrug was not significantly (P > 0.05) different from their respective normal controls. In the mice experiments, the superior retinal ⌬PO 2 of the iNOS null mice was not statistically different (P > 0.05) from that of normal control mice. iNOS is required for the development of an early subnormal ⌬PO 2 in experimental diabetic retinopathy. Diabetes 53: [173] [174] [175] [176] [177] [178] 2004 N itric oxide (NO), a potent regulator of retinal vascular function, is elevated in the vitreous humor of patients with proliferative diabetic retinopathy and with tractional retinal detachment, as well as in the retina of rodents, 2-4 months after the induction of diabetes (1) (2) (3) (4) . NO synthase (NOS) converts L-arginine to NO and L-citrulline. Excessive NO production by the inducible isoform of NOS (iNOS) in particular has been implicated in the pathogenesis of various ocular diseases (5, 6) . iNOS is induced in the retina in diabetes, but it is not yet known if iNOS regulates aspects of retinal circulatory pathophysiology associated with diabetes (4) .
Previously, we developed a novel functional magnetic resonance imaging (MRI) method for measuring the retinal oxygenation response to a hyperoxic inhalation challenge in the newborn and adult rat, rabbit, cat, and human (7) (8) (9) (10) . In this technique, hyperoxia increases vitreous partial oxygen pressure over room-air values (⌬PO 2 ). Because oxygen is paramagnetic, this ⌬PO 2 will produce an increase in the vitreous signal intensity on a T 1 -weighted image. Furthermore, good agreement is found between the MRI-measured response and that determined by other investigators (11) using an oxygen electrode in normal rat retina under similar conditions. In normal adult and newborn rats, carbogen breathing oxygenated the retina significantly better than pure oxygen breathing (11) . Carbogen is a gas mixture of carbon dioxide (5%) and oxygen (95%) that has been used clinically, instead of 100% oxygen, to minimize the vasoconstrictive effects of pure O 2 on retinal blood flow and oxygenation.
The usefulness of the functional MRI approach has been tested in experimental diabetes models that reliably develop retinal histopathology (e.g., acellular capillaries and pericyte ghosts) after 15 months of hyperglycemia. In these models, 3-4 months after the induction of diabetes (before the appearance of retinal lesions), a subnormal retinal ⌬PO 2 during carbogen breathing was observed (7, 9) . Aminoguanidine (AMG) treatment initiated with the induction of diabetes preserved the retinal oxygenation response at the 3-month time point and prevented the development of retinal histopathology at 15 months (9) . Consistent with these results, 2 months of treatment with AMG, a relatively selective inhibitor of iNOS activity, also significantly inhibited nitrative stress in diabetic rat retina (4) . In contrast, AMG treatment of galactosemic rats did not preserve the retinal oxygenation response at 3 months or prevent the development of retinal lesions at 15 months (7, 9) . Together these results suggest that correction of the early subnormal retinal ⌬PO 2 is a useful surrogate marker of treatment efficacy.
The present study tests the hypothesis that iNOS con-tributes to the early development of a subnormal ⌬PO 2 in diabetic rodents. We compared the effect of both pharmacological and genetic iNOS inhibition on the retinal ⌬PO 2 in diabetic rat and mouse models, respectively.
RESEARCH DESIGN AND METHODS
The animals were treated in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and the Association for Research in Vision and Ophthalmology statement on animals in vision research. Animal model. Two experimental models of diabetic retinopathy were studied: the diabetic rat and mouse. Each diabetic group started with 15-20 animals. Animals were fed normal rat chow (5001; Ralston Purina, Richmond, IN) and water ad libitum. Rats were maintained in three groups for 3 months: controls (CR; n ϭ 9), untreated diabetes (DR; n ϭ 5), and diabetes treated with the prodrug L-N(6)-(1-iminoethyl)lysine 5-tetrazole amide (12) (100 ppm; DϩPRO; n ϭ 6). Prodrug was administered in the chow (i.e., 100 mg compound/kg of chow). The average daily dose depends on the amount of chow consumed (e.g., a 200-g rat consuming ϳ20 g of chow per day will receive a dose of ϳ10 mg/kg body wt). Diabetes was induced in rats (starting weight 200 -220 g) with an intraperitoneal injection of streptozotocin (55 mg/kg, 0.01 mol/l citrate buffer, pH 4.5) after a 24-h fast and verified 24 h later by the presence of plasma hyperglycemia and glucosuria in nonfasted rats. Rat body weight, average food consumption, and blood glucose levels were monitored weekly. Subtherapeutic levels of insulin (0 -4 units of neutral protamine Hagedorn [NPH] insulin administered subcutaneously up to 7 days per week, as needed) were administered to allow slow weight gain, yet maintain hyperglycemia and glucosuria. The diabetic animals produced in this study had mean plasma glucose levels of Ͼ400 but Ͻ550 mg/dl (Table 1) .
Control (C57BL/6J [CM]) and iNOS null (C57BL/6-Nos2 tm1Lau [KO]) mice were purchased from the Jackson Laboratories. The iNOS null mice are viable fertile, nonhypertensive, and have been routinely studied for up to 6 months (V. Laubach, personal communication) (13) . Diabetes was induced in C57BL/6J (DM) and in iNOS null (DϩKO) mice (starting weight 24 -26 g) with streptozotocin (55 mg/kg, 0.01 mol/l citrate buffer, pH 4.5, i.p.) injection once a day for 5 consecutive days. Each day, the food was removed at 8:00 A.M., the animals were injected with streptozotocin at 4:00 P.M., and the food returned. Normal rodent chow and water were provided ad libitum. Body weight was monitored daily and blood glucose levels weekly. Low-dose insulin was administered as needed to maintain a slow weight gain while maintaining the diabetic state in the mouse. After 4 months of diabetes, only those mice with blood glucose levels that were maintained between 400 and 550 mg/dl were studied by MRI. Measurement of NO. In CR (n ϭ 7 rats), DR (3 months, n ϭ 6 rats), and DϩPRO (3 months, n ϭ 6 rats), both eyes were enucleated and retinas rapidly removed from urethane-anesthetized animals and frozen. As previously described, NO levels were indirectly determined from the concentration of stable metabolites of NO (nitrate plus nitrite) and measured using a fluorimetric assay kit (Cayman Chemical, Ann Arbor, MI) (4). Briefly, retinal homogenates were first filtered (10 kDa) and then incubated again with nitrate reductase for 2 h. Fluorescence generated by nitrite reaction with 2,3-diaminonaphthalene was measured. In all cases, samples were assayed simultaneously. MRI exam. On the day of the experiment, anesthesia was induced by a single intraperitoneal injection of urethane (36% solution, 0.083 ml/20 g body wt, prepared fresh daily; Aldrich, Milwaukee, WI). Each animal was gently positioned on an MRI-compatible homemade holder with its nose placed in a plastic nose cone. Animals were allowed to breathe spontaneously during the experiment. To maintain the core temperature, a recirculating heated water blanket was used. Rectal temperature, pulse, and hemoglobin oxygen saturation (data not shown) were continuously monitored while the animal was inside the magnet, as previously described (9) .
MRI data were acquired on a 4.7 T system using a two-turn transmit/receive surface coil (1.5-cm diameter) placed over the eye. Images were acquired using an adiabatic spin-echo imaging sequence (repetition time [ (14) . This resulted in an in-plane resolution of 250 ϫ 125 m 2 (rat) and 141 ϫ 70 m 2 (mouse). Examining the initial retinal oxygenation response to a hyperoxic challenge requires careful attention to experimental timing and makes high demands on the animals' physiology compared with steady state measurements. We reason that the retinal circulation is often required to maintain an adequate oxygenation level under different conditions (e.g., standing up versus sitting down), and the hyperoxic challenge acts as an acute "stress" test of the retinal circulation's ability to oxygenate. Other stress tests (e.g., response to hypoxia and/or reduced blood pressure) can also be envisioned. However, relatively smaller signal intensity changes are expected from these challenges compared with that found during carbogen breathing. This would likely make analysis of the data difficult to detect/interpret. In the present study, we chose to use a carbogen challenge because large signal intensity changes are produced in both rat (11) and mouse (data not shown), allowing for the detection of subtler pathophysiology.
The MRI data were collected as follows. Sagittal localizer images were first collected and used to position a single 1-mm transverse slice through the center of the eye. The 1-mm slice thickness was needed to obtain an adequate signal-to-noise ratio in a 2-min image. This slice thickness resulted in some partial volume averaging so that the final image contained superior and inferior hemiretina with some relatively minor contribution from temporal and nasal hemiretina. A capillary tube (1.5-mm inner diameter) filled with distilled water was used as the external standard (not shown in Fig. 1 ). It is important to note that steady state (room air) vitreous oxygen tension cannot be measured using this method because many factors affect the preretinal vitreous water signal and its relaxation properties. In other words, simply 
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obtaining an image of the eye during room air breathing alone cannot be used to measure retinal oxygenation. Data were collected as follows: three images while the animal breathed room air and one image during the inhalation of carbogen. Carbogen inhalation was started at the end of the third image. Animals were returned to room air for 5 min to allow recovery from the inhalation challenge and were removed from the magnet. A second 2-min inhalation challenge was performed outside the magnet with care taken to not alter the spatial relationship between the animal head and nose cone. At exactly 2 min, arterial blood from the descending abdominal aorta was collected as previously described (11) . This blood was analyzed for glucose, P a O 2, P a CO 2 , and pH. Note that this second inhalation challenge (outside the magnet) is needed because it is not feasible to routinely obtain an arterial blood sample from inside the magnet (Ͼ40 cm away from the magnet opening) from rats or mice. In all cases, after the blood collection, animals were killed with an intracardiac potassium chloride injection. Data analysis. To be included in this study, the animal must have demonstrated the following traits. 1) There had to be minimal eye movement during the MRI exam. Movement artifacts (typically seen in the phase-encode direction) will confound interpretation of the vitreous signal intensity changes produced during the hyperoxic challenge.
2) The animal had to have a nongasping respiratory pattern before and after the MRI exam. If the animal is gasping, which occurred Ͻ1% of the time, the anesthetic was likely improperly administrated (e.g., not intraperitoneally). This could produce a change in systemic oxygenation unrelated to the retinal changes. 3) Rectal temperatures in the range 35.5-36.5°C had to be observed. Preliminary experiments (data not shown) found a strong association between core temperature and P a CO 2 and P a O 2 levels. The effect of this correlation on the precision of the measurements was minimized by using a relatively tight range of temperatures. 4) Finally, P a O 2 Ͼ350 mmHg and P a CO 2 between 46 and 65 mmHg during the carbogen challenge had to be observed. Previously, we found (15) that arterial oxygen levels Ͼ350 mmHg during a hyperoxic challenge were needed to produce a consistently large preretinal vitreous oxygenation response. The range of acceptable arterial carbon dioxide levels lie within the array of values in the literature measured under carbogenbreathing conditions. In addition, tight control over the acceptable blood gas value range is needed to ensure adequate quality control of each sample. Occasionally, the blood gas machine was not able to read a sample (e.g., due to a clot or excessive air in the capillary tube). In this case, the MRI data were also excluded. In general, ⌬PO 2 data were collected ϳ60 min (rats) or 90 min (mice) after urethane injection to avoid potential errors due to variable time under anesthesia. The above acceptance criteria are needed to critically compare the retinal oxygenation response in these spontaneously breathing normal and sick animals while minimizing systemic differences. Because such tight criteria are used, only ϳ50% of the animals that started the study were used in the final analysis. Based on our previous experience in rats, n Ն 5 is sufficient to draw statistical conclusions.
To correct for any movement in the slice plane, a warp affine image coregistration was performed on each animal using software written in-house. This was done for all of the animals used in the final analysis but was only necessary in about half of them regardless of group (e.g., subtle shifting of the animals' position occurred during the experiment due to settling on the gauze packing). Because the slice thickness (1 mm) is relatively large compared with the diameter of the eye (ϳ3 mm), partial volumes will be similar if the eye subtly moves out of the imaging plane, and so the data analysis results were not expected to be substantially affected. After coregistration, the MRI data were transferred to a Power Mac G4 computer and analyzed using the program NIH IMAGE (a freeware program available at http://rsb.info.nih.gov/ nih-image). Images obtained during room air breathing were averaged to improve the signal-to-noise ratio. All pixel signal intensities in the average room air image and the 2-min carbogen image were then normalized to the external standard intensity. Signal intensity changes during carbogen breathing were calculated and converted to ⌬PO 2 values, on a pixel-by-pixel basis, as follows (11) . For each pixel, the fractional signal enhancement E was calculated as E ϭ [S(t) Ϫ S 0 ]/S 0 , where S(t) is the pixel signal intensity at time (t) after starting the gas inhalation and S 0 is the control signal intensity (measured from the average of the three control images) at the same pixel spatial location. E values were converted into ⌬PO 2 using a theory that has been validated in the rat (16): ⌬PO 2 ϭ E/(R 1 ϫ T k ), where R 1 is the oxygen relaxivity (s Ϫ1 mmHg Ϫ1 ), and T k ϭ T r ϫ exp(ϪT r /T 10 ), where T r is the repetition time and T 10 is the T 1 in the absence of oxygen. Using a T r of 1 s, and assuming a vitreous T 10 of 4 s, T k ϭ 3.52. This T 10 value is based on our previous measurement of the proton spin-lattice relaxation time in the rabbit vitreous (4 s), reported values in human vitreous (3.3 s), and in cerebral spinal fluid (4.3 s), which has a similar high water content as vitreous (11, (17) (18) (19) ). An R 1 of 2 ϫ 10 Ϫ4 s Ϫ1 mmHg Ϫ1 was used. This R 1 was previously measured in a saline phantom, which is assumed to be a reasonable model of vitreous (98% water) (11) . A similar R 1 value was found for plasma, suggesting that relatively low protein levels do not substantially contribute to oxygen relaxivity (20) . Note that an E of 0.01 (i.e., a 1% signal intensity change) corresponds to a ⌬PO 2 of 14 mmHg. There did not appear to be any significant changes in vitreous T 10 or R 1 in the animals of this study, based on the similar inferior hemiretinal oxygenation response found in all of the groups in this study.
The ⌬PO 2 parameter image was analyzed as follows. First, the pixel values along a 1-pixel thick line drawn at the boundary of the retina/choroid and vitreous were set to 255 (black). We estimated that the thickness of this line, based on the in-plane resolution (e.g., in the mouse, an 18 ϫ 18 mm 2 field of view was sampled by 128 ϫ 256 datapoints) of 140 ϫ 70 m 2 , is ϳ100 m. The values in another 1-pixel thick line drawn in the preretinal vitreous next to the black pixels were then extracted (21) . This procedure minimized retinal/ choroid pixel values from potentially contaminating ("pixel bleed") those used in the final analysis and insured that similar preretinal vitreous space was sampled for each animal. In addition, spatial averaging over these 100-m regions of interest will tend to minimize the contribution from the very local preretinal oxygenation gradients next to the retinal surface (22) . In addition, an average ⌬PO 2 band was constructed based on the within-group mean for each pixel. Statistical analysis. The physiological parameters (i.e., blood gas values, rectal temperatures, and blood glucose data) were normally distributed and are presented as mean Ϯ SE. Comparisons were performed using an unpaired t test. Comparison of retinal ⌬PO 2 between control and experimental groups was performed using a generalized estimating equation approach. This method performs a general linear regression analysis using all of the pixels in each subject and accounts for the within-subject correlation between adjacent pixels. In all cases, a P Յ 0.05 was considered significant.
RESULTS
Systemic physiology. A summary of the rat and mouse systemic physiology is presented in Tables 1 and 2 , respectively. As expected, compared with control rats and mice, all diabetic animals had significantly (P Ͻ 0.05) elevated blood glucose levels. There were no significant (P Ͼ 0.05) differences in plasma glucose levels between the DR and DϩPRO groups or between the DM and ϪDϩKO groups.
A summary of the blood parameters measured during a 2-min hyperoxic challenge and core temperature during the experiment are also presented in Tables 1 and 2 . The P a O 2 , pH, and core temperature were not significantly (P Ͼ 0.05) different among any of the rat groups (Table 1) . Although the P a CO 2 values were significantly lower (P Ͻ 0.05) in the DϩPRO group compared with those of the DR groups, this degree of arterial hypercapnia is within the range expected during carbogen breathing. Thus, this difference was not considered to be of physiologic significance. The P a O 2 , P a CO 2 , pH, and core temperature were not significantly (P Ͼ 0.05) different among any of the mouse groups (Table 2) . Drug treatment. Plasma prodrug levels at midstudy (1.5 month) and at the end of study (3 months) were ϳ15 mol/l, which is above the IC 50 for iNOS (ϳ5 mol/l) and below the IC 50 for endothelial NOS (Ͼ100 mol/l) and neuronal NOS (50 mol/l). The retinal NO level was evaluated using nitrite and nitrate, the stable metabolites of NO. Compared with CR, the retinal concentration of nitrite plus nitrate in DR was elevated ϳ1.5-fold (5.3 Ϯ 0.6 vs. 8.1 Ϯ 1.2 pmol/mg protein, P Ͻ 0.05, respectively), and in DϩPRO animals (2.7 Ϯ 0.28 pmol/mg protein, P Ͻ 0.05), the concentration was significantly less than that of DR. These data are consistent with selective inhibition of iNOS in the DϩPRO group. Functional MRI. MRI provides a clear image of rodent ocular anatomy in vivo, including the retina/choroid complex (seen as a white line in the posterior region of the eye) and the nucleus and cortex of the lens ( Fig. 1 ) (7). No significant (P Ͼ 0.05) differences were found in average inferior hemiretinal ⌬PO 2 comparing any of the rat or mouse groups with their respective normal, nondiabetic controls (CR 169 Ϯ 6 mmHg, DR 121 Ϯ 6, DϩPRO 214 Ϯ 9, CM 129 Ϯ 4, DM 142 Ϯ 6, KO 171 Ϯ 6, and DϩKO 147 Ϯ 9; mean Ϯ SE). The mean superior hemiretinal ⌬PO 2 of the iNOS knockout mice was not significantly (P Ͼ 0.05) different from that of controls (Fig. 2) . As expected, the average superior hemiretinal ⌬PO 2 of the 3-month diabetic rats and 4-month diabetic mice were significantly (P Ͻ 0.05) subnormal (9) (Fig. 2) . In treated diabetic rats and in the diabetic iNOS knockout mice, the mean superior 
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hemiretinal ⌬PO 2 values were not different (P Ͼ 0.05) from that of their respective controls (Figs. 2-4) . To examine the regional effect of iNOS inhibition in diabetic rats and mice, we compared plots of the average superior hemiretinal pixel ⌬PO 2 values versus pixel position (i.e., distance) from the optic nerve head. As seen in Figs. 3 and  4 , there is clear evidence that diabetic iNOS-inhibited rodents experienced a pansuperior retinal correction in ⌬PO 2 .
DISCUSSION
In this study, we confirmed that diabetic rats experience an increased production of retinal NO (4) and that a relatively specific inhibitor of iNOS activity [prodrug of L-N(6)-(1-iminoethyl)lysine 5-tetrazole amide] prevented this accumulation of retinal NO. In addition, we found a subnormal superior hemiretinal ⌬PO 2 in rat and mouse models of diabetic retinopathy and examined the contribution of iNOS to this diabetes-induced pathophysiology. Phenotyping requires an accurate measurement of the retinal ⌬PO 2 . Previously, we reported agreement between functional MRI and oxygen electrode ⌬PO 2 data in control rats. In addition, no significant differences (P Ͼ 0.05) were found in the inferior hemiretinal ⌬PO 2 between any of the groups studied. These considerations provide confidence in the assumed T 10 and R 1 values used in the second equation and imply that potential artifacts (such as those from data scatter or mixing of vitreous from outside the slice) do not confound data interpretation in the rat or mouse. Retinal oxygen measurements using a microelectrode have not been performed in the mouse, so it is not possible to fully determine the accuracy of the murine functional MRI measurement. However, similar ⌬PO 2 values were found in control rats and mice (Fig. 2) . Together, these considerations strongly support the accuracy of the functional MRI ⌬PO 2 measurement in rats and mice.
The subnormal superior hemiretinal ⌬PO 2 found in 3-month diabetic rats and 4-month diabetic mice appears to be an early event in the sequence leading to histopathology in diabetes. Furthermore, treatments that prevented retinal lesion formation in long-term diabetic and galactosemic rats also prevented the development of a subnormal superior hemiretinal ⌬PO 2 in more acute studies (9). These observations strongly suggest that subnormal superior hemiretinal ⌬PO 2 is an early functional lesion that predicts the development of the structural lesions. The vascular lesions of diabetic retinopathy in rats or mice take longer to develop than the 3-to 4-month duration used in the present study (7, 23, 24) , so we cannot currently evaluate the relation of NO to the development of histopathology. It was beyond the scope of this study to determine why the superior hemiretinal ⌬PO 2 becomes subnormal and the inferior hemiretinal does not. Nonetheless, based on the above, it appears that subnormal retinal ⌬PO 2 occurs before the appearance of experimental diabetic retinopathy.
Previous studies have shown that in diabetic rats, AMG, which is a relatively selective inhibitor of iNOS activity (among other actions), significantly inhibited diabetesinduced nitrative stress by 2 months, corrected the development of a subnormal superior hemiretinal ⌬PO 2 by 3 months, and prevented the development of significant retinal histopathology by 15 months (4, 9, 25) . However, based on these data, the association between diabetesinduced iNOS and the development of a subnormal ⌬PO 2 is indirect. The major finding in this study is that the inhibition of iNOS activity, either pharmacologically or genetically, prevented development of a subnormal supe- rior hemiretinal ⌬PO 2 in diabetic rodents. One possible implication of the present study is that diabetes induces a greater increase in iNOS activity (and presumably NO level) in the superior hemiretina than in the inferior hemiretina. More work is needed to test this hypothesis.
The exact mechanism(s) by which iNOS produces a subnormal ⌬PO 2 remains unclear. In diabetic rats and mice, chronic hyperglycemia produces an elevated retinal iNOS expression resulting in increased NO levels (3, 4) . Such nitrative stress may produce chronic vasodilatation that, coupled with other complications of diabetes, such as increased advanced glycated end products, could prevent the retinal vessel endothelium from responding appropriately to a carbogen challenge. Experiments are ongoing in the laboratory to further evaluate this speculation. It remains to be determined whether diabetic rodents treated with a specific inhibitor of iNOS activity will have subsequent retinal histopathology. Nonetheless, the present data establish that diabetes-induced increased iNOS activity as a key step in the development of early diabetic pathophysiology.
